Neoadjuvant FOLFOX Chemotherapy for Colon Cancer: Long-Term Chemotherapy-Induced Peripheral Neuropathy and Impact on Quality of Life
Clinical trial NCT06844409 · COMPLETED
Trial details
- NCT number
- NCT06844409
- Sponsor
- P. Herzen Moscow Oncology Research Institute
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2021-03-19
- Primary completion
- 2024-05-20
- Enrollment
- 54
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.